Form 483

SOCIETAL CDMO SAN DIEGO, LLC Form 483, 2011-10-21

FDA issued a Form 483 to SOCIETAL CDMO SAN DIEGO, LLC on 2011-10-21 with 6 public-safe observations.

483· Form 483 issued6 observations

SOCIETAL CDMO SAN DIEGO, LLC · San Diego, United States · Issued October 21, 2011

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Oct 2011
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Virgilio F Pacio

21 Oct 2011
21 CFR 211.68(b)

Computer control of master formula records

Cited by Virgilio F Pacio

21 Oct 2011
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Virgilio F Pacio

21 Oct 2011
21 CFR 211.110(a)

Control procedures fail to include the following

Cited by Virgilio F Pacio

21 Oct 2011
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Virgilio F Pacio

Inspected site

SCSOCIETAL CDMO SAN DIEGO, LLCSan Diego, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere